BPC-157 and the Science of Tissue Repair
A gastric peptide with an outsized reputation in recovery circles. What the mechanism supports — and what it doesn't.
BPC-157 is a synthetic fragment of a protein found in gastric juice. Its most consistent finding across preclinical work is angiogenesis — new blood vessel formation at sites of injury.
Why blood flow is the mechanism that matters
Tendon, ligament and gut lining heal slowly largely because they are poorly vascularized. A compound that increases local perfusion changes the ceiling on repair rate.
Where the evidence is strongest
Gastrointestinal protection and soft-tissue healing dominate the literature. Human trial data remain limited, which is exactly why supervision and honest expectation-setting matter.
How it is used clinically
Courses are typically short and goal-bound — a defined injury or gut protocol — rather than continuous. Response is judged against function, not sensation.
Frequently asked
Is BPC-157 FDA approved?
It is not an FDA-approved drug product. It is prescribed and compounded under physician supervision, and your provider will explain that status during consultation.
How is BPC-157 taken?
Commonly as a subcutaneous injection near the target area, or orally for gut-focused protocols.
This article is educational and is not medical advice. Treatment decisions are made by a licensed provider after a clinical evaluation.
